Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

IVA Inventiva S.A.

Pre-Mkt 04-16 06:25:40 EDT

5.74

+0.23

+4.17%

盘前5.60

-0.14-2.44%

05:26 EDT

High5.80	Low5.44	Vol653.64K
Open5.52	D1 Closing5.51	Amplitude6.53%
Mkt Cap1.19B	Tradable Cap694.54M	Total Shares208.00M
T/O3.71M	T/O Rate0.54%	Tradable Shares121.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":5.74,"timestamp":1776283200000,"preClose":5.51,"halted":0,"volume":653639,"hourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":5.74,"latestTime":"05:26 EDT","volume":9378,"amount":52199.364078,"timestamp":1776331606987,"change":-0.14,"changeRate":-0.02439,"amplitude":0.027875},"delay":0,"changeRate":0.04174228675136124,"floatShares":121000000,"shares":208000000,"eps":-2.230832,"marketStatus":"Pre-Mkt","change":0.23,"latestTime":"04-16 06:25:40 EDT","open":5.52,"high":5.8,"low":5.44,"amount":3714112.2984,"amplitude":0.065336,"askPrice":5.57,"askSize":680,"bidPrice":5.47,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.230832,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1776346200000},"marketStatusCode":1,"adr":0,"adrRate":1,"listingDate":1594353600000,"exchange":"NASDAQ","adjPreClose":5.74,"preHourTrading":{"tag":"盘前","latestPrice":5.6,"preClose":5.74,"latestTime":"05:26 EDT","volume":9378,"amount":52199.364078,"timestamp":1776331606987,"change":-0.14,"changeRate":-0.02439,"amplitude":0.027875},"postHourTrading":{"tag":"盘后","latestPrice":5.74,"preClose":5.74,"latestTime":"16:04 EDT","volume":2,"amount":11.48,"timestamp":1776283487965,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9449307457680128},"requestUrl":"/m/hq/s/IVA","defaultTab":"news","newsList":[{"id":"2625993257","title":"Analysts Are Bullish on These Healthcare Stocks: Inventiva (IVA), Stereotaxis (STXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625993257","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625993257?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:50","pubTimestamp":1775559056,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Stereotaxis (STXS) and Merck & Comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inventiva-iva-stereotaxis-stxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-inventiva-iva-stereotaxis-stxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0058720904.USD","LU0130102774.USD","LU0211331839.USD","LU0203345920.USD","LU1989772840.SGD","LU1037948541.HKD","LU0122379950.USD","BK4007","LU1023059063.AUD","MRK","BK4559","LU0985320562.USD","LU0070302665.USD","LU1037948897.HKD","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0965509283.SGD","LU0965509010.AUD","LU0098860793.USD","BK4588","BK4585","LU0029874061.USD","LU1035773651.USD","SG9999014542.SGD","LU0006306889.USD","LU1989771016.USD","LU2023250504.SGD","LU0203347892.USD","BK4139","LU1066051498.USD","IE000M9KFDE8.USD","LU1934455277.USD","LU2324357040.USD","LU2361044949.HKD","LU1057294990.SGD","LU0942090050.USD","LU2360032135.SGD","LU0208291251.USD","LU0238689110.USD","LU1983299246.USD","LU1917777945.USD","LU1934455863.HKD","IE00BBT3K403.USD","BLSX","LU1066053197.SGD","LU2361045086.USD","SG9999002232.USD","LU0265550946.USD","LU2461242641.AUD","LU1116320737.USD","LU2023250843.SGD","LU1116320901.HKD","LU0320765646.SGD","LU1929549753.HKD","SG9999015341.SGD","LU2106854487.HKD","LU0980610538.SGD","LU1093756168.USD","LU1974910355.USD","SG9999001176.SGD","LU0130517989.USD","SG9999002224.SGD","LU0234572021.USD","LU0289739699.SGD","LU0266013472.USD","LU0477156953.USD","SG9999014575.USD","SG9999015358.SGD","IE00BJT1NW94.SGD","LU2112291526.USD","IE00B4R5TH58.HKD","LU2125154935.USD","LU1061106388.HKD","LU1699723380.USD","IE00BLSP4239.USD","LU1941712348.USD","LU1201861249.SGD","IE00BJJMRZ35.SGD","BK4533","LU0868494708.USD","LU1934455194.USD","SG9999001176.USD","LU0648001328.SGD","LU1585245621.USD","LU1069347547.HKD","LABU","LU1066051225.USD","BK4137","BK4112","LU2361044865.SGD","LU1430594728.SGD","LU0868494617.USD","LU1291159041.SGD","SG9999014567.USD","LU2468319806.SGD","LU1162221912.USD","LU1093756325.SGD","LU0106261372.USD","SG9999001440.SGD","BK4516","BK4534","LU0965509101.SGD","IE00BFTCPJ56.SGD","BK4581","IE0009355771.USD","SG9999013999.USD","BLSG","IVA","LU1941712264.USD","SG9999014559.SGD","LU0128526141.USD","LU1066051811.HKD","XBI","LU0265550359.USD","LU0432979614.USD","BK4550","LU0965508806.USD","LU0861579265.USD","IE0002141913.USD","LU2089984988.USD","LU2125154778.USD","IE00BSNM7G36.USD","LU0320765489.SGD","IE00B1BXHZ80.USD","BK4082","STXS","IE00BN8TJ469.HKD","LU1989772923.USD","IE00B2B36J28.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624574124","title":"Barclays Sticks to Its Buy Rating for Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624574124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624574124?lang=en_us&edition=fundamental","pubTime":"2026-04-02 16:49","pubTimestamp":1775119788,"startTime":"0","endTime":"0","summary":"Barclays analyst Eliana Merle maintained a Buy rating on Inventiva today and set a price target of $18.00. According to TipRanks, Merle is a 3-star...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-buy-rating-for-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624901535","title":"Guggenheim Keeps Their Buy Rating on Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624901535","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624901535?lang=en_us&edition=fundamental","pubTime":"2026-04-01 19:17","pubTimestamp":1775042253,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Seamus Fernandez reiterated a Buy rating on Inventiva today and set a price target of $11.00. Fernandez covers the Healthcare se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-keeps-their-buy-rating-on-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160010640","title":"Stock Track | Inventiva S.A. Soars 6.02% Intraday on Analyst Bullishness","url":"https://stock-news.laohu8.com/highlight/detail?id=1160010640","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160010640?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:44","pubTimestamp":1774971870,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) saw its stock price surge by 6.02% during Tuesday's intraday session, reflecting significant positive investor sentiment.The sharp increase appears to be driven by recent bullish...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623535330","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2623535330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623535330?lang=en_us&edition=fundamental","pubTime":"2026-03-31 23:30","pubTimestamp":1774971010,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), PolyPid (PYPD) and Soligenix (SNGX)...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-84?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-84?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BLSX","IVA","SNGX","BK4007","XBI","LABU","LU0029874061.USD","BK4112","BK4139","BK4585","BLSG","BK4137","PYPD","LU0128526141.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623533152","title":"Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623533152","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623533152?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:50","pubTimestamp":1774968608,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-neumora-therapeutics-inc-nmra-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-inventiva-iva-neumora-therapeutics-inc-nmra-and-gain-therapeutics-ganx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","IVA","BK4588","LU0029874061.USD","XBI","BK4585","BK4581","GANX","BK4139","BK4007","LABU","XLV","LU0128526141.USD","NMRA","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164749330","title":"Stock Track | Inventiva Plunges 14.6% in Pre-market After Reporting Steep Revenue Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=1164749330","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164749330?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:20","pubTimestamp":1774945235,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) experienced a significant pre-market plunge, with shares falling 14.60%.The sharp decline follows the company's release of its 2025 financial results, which showed revenue...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623321531","title":"Inventiva 2025 Loss Narrows, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2623321531","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623321531?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:49","pubTimestamp":1774903752,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) reported a fiscal 2025 net loss late Monday of 1.90 euros ($2.18) per diluted share, narrowing from a loss of 3.08 euros a year earlier.Revenue for the year ended Dec. 31 was 4.5 million euros, down from 9.2 million euros a year earlier.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623732997","title":"Earnings Flash (IVA) Inventiva Posts 2025 Revenue 4.5 Million Euros","url":"https://stock-news.laohu8.com/highlight/detail?id=2623732997","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623732997?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:23","pubTimestamp":1774902187,"startTime":"0","endTime":"0","summary":"Earnings Flash (IVA) Inventiva Posts 2025 Revenue 4.5 Million Euros","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155846645","title":"Stock Track | Inventiva Plummets 5.77% Intraday After Missing Earnings and Sales Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=1155846645","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155846645?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:18","pubTimestamp":1774901914,"startTime":"0","endTime":"0","summary":"Inventiva S.A. (IVA) saw its stock price plummet 5.77% during intraday trading on Monday, following the release of disappointing quarterly financial results.The biopharmaceutical company reported...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623295723","title":"Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2623295723","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623295723?lang=en_us&edition=fundamental","pubTime":"2026-03-31 04:15","pubTimestamp":1774901751,"startTime":"0","endTime":"0","summary":"Inventiva (NASDAQ:IVA) reported quarterly losses of $(2.14) per share which missed the analyst consensus estimate of $(1.66) by 28.92 percent. This is a 35.74 percent increase over losses of $(3.33) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51552957/inventiva-fy-eps-2-14-misses-1-66-estimate-sales-5-064m-miss-6-000m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Inventiva FY EPS $(2.14) Misses $(1.66) Estimate, Sales $5.064M Miss $6.000M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622384759","title":"LifeSci Capital Sticks to Their Buy Rating for Inventiva (IVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622384759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622384759?lang=en_us&edition=fundamental","pubTime":"2026-03-28 22:38","pubTimestamp":1774708702,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Inventiva today and set a price target of $14.00. Katkhuda covers the Healthcare s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-their-buy-rating-for-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-their-buy-rating-for-inventiva-iva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622875497","title":"Inventiva SA  expected to post a loss of 24 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2622875497","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622875497?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:30","pubTimestamp":1774625443,"startTime":"0","endTime":"0","summary":"Inventiva SA  expected to post a loss of24cents a share - Earnings Preview Inventiva SA IVA.OQ, IVA.O is expected to  report resultson March 30 for the period ending December 31 2025LSEG's mean analys","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL8N40F1HG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163690526","title":"Earning Preview: Inventiva S.A. this quarter’s revenue is expected to decrease by 100%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1163690526","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163690526?lang=en_us&edition=fundamental","pubTime":"2026-03-23 11:39","pubTimestamp":1774237187,"startTime":"0","endTime":"0","summary":"Title Earning Preview: Inventiva S.A. this quarter’s revenue is expected to decrease by 100%, and institutional views are bullish Abstract Inventiva S.A. is scheduled to report on March 30, 2026...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Earning Preview: Inventiva S.A. this quarter’s revenue is expected to decrease by 100%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620312241","title":"Truist Initiates Inventiva at Buy With $13 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2620312241","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620312241?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:41","pubTimestamp":1773916914,"startTime":"0","endTime":"0","summary":"Inventiva (IVA) has an average rating of buy and mean price target of $14.90, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620249636","title":"Inventiva Initiated at Buy by Truist Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2620249636","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620249636?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:22","pubTimestamp":1773915720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 19, 2026 06:22 ET (10:22 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620608213","title":"Inventiva Sa : Truist Securities Initiates Coverage With Buy Rating; Target Price $13","url":"https://stock-news.laohu8.com/highlight/detail?id=2620608213","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620608213?lang=en_us&edition=fundamental","pubTime":"2026-03-19 12:07","pubTimestamp":1773893228,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nFWN406156:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620902262","title":"Inventiva initiated with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2620902262","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620902262?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:15","pubTimestamp":1773864917,"startTime":"0","endTime":"0","summary":"Truist initiated coverage of Inventiva (IVA) with a Buy rating and $13 price target Lead asset lanifibranor has a unique mechanism and profile amon...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/inventiva-initiated-with-a-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/inventiva-initiated-with-a-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606710629","title":"Inventiva Initiated at Overweight by Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2606710629","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606710629?lang=en_us&edition=fundamental","pubTime":"2026-01-28 22:50","pubTimestamp":1769611800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 28, 2026 09:50 ET (14:50 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602643517","title":"Inventiva Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2602643517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602643517?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:46","pubTimestamp":1768221960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IVA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 12, 2026 07:46 ET (12:46 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.inventivapharma.com","stockEarnings":[{"period":"1week","weight":0.083},{"period":"1month","weight":-0.0559},{"period":"3month","weight":-0.0621},{"period":"6month","weight":0.1835},{"period":"1year","weight":0.6872},{"period":"ytd","weight":0.2344}],"compareEarnings":[{"period":"1week","weight":0.0354},{"period":"1month","weight":0.0462},{"period":"3month","weight":0.0111},{"period":"6month","weight":0.0535},{"period":"1year","weight":0.3019},{"period":"ytd","weight":0.0264}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of mucopolysaccharidoses type VI disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.098872},{"month":2,"riseRate":0.666667,"avgChangeRate":0.043927},{"month":3,"riseRate":0,"avgChangeRate":-0.112386},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.062353},{"month":5,"riseRate":0.6,"avgChangeRate":0.107821},{"month":6,"riseRate":0.2,"avgChangeRate":-0.118686},{"month":7,"riseRate":0.4,"avgChangeRate":-0.068338},{"month":8,"riseRate":0.333333,"avgChangeRate":0.149729},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.0365},{"month":10,"riseRate":0.666667,"avgChangeRate":0.071747},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.025201},{"month":12,"riseRate":0.833333,"avgChangeRate":0.034174}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Inventiva S.A.(IVA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction